SCHIZOPHRENIA 1 (Disorder): Clinical Trials

2 trials for SCHIZOPHRENIA 1 (Disorder), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 2

Follow SCHIZOPHRENIA 1 (Disorder): new trials by email Literature Review of SCHIZOPHRENIA 1 (Disorder) trials Research Report on SCHIZOPHRENIA 1 (Disorder)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults
HS-10380, Aripiprazole, Placebo - SCHIZOPHRENIA 1 (Disorder)
Phase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.4762026-11-042026-11-03
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
HS-10380 - SCHIZOPHRENIA 1 (Disorder)
Phase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.5002026-09-092026-08-12

Narrower conditions

Schizophrenia (2)

Broader conditions

Mental Disorders (2)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (2)

Interventions

Aripiprazole (1)

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd. (2)

Countries

China (2)